دارو ابوریحان (حق تقدم)
دابورح |
Warrant
-
Exchange
دارویی ( داروهای شیمیایی و گیاهی )
Category:
دارویی
Sub Category:
داروهای شیمیایی و گیاهی
Status:
Prohibited-bourse.motevaghef
Last:
21,550
1.08
Close:
21,470
0.70
EPS
Last Capital
Estimated Capital
Fiscal year 2023-03-20
1,835
Achieved
Date | Profit | Capital | ||
---|---|---|---|---|
Date : 2023-01-18 9 Months |
Forecast :
Achieved :
|
0.001,835.00 (0٪) |
Capital : 1.8 Thousand billion |
|
Date : 2022-11-20 6 Months / Audited |
Forecast :
Achieved :
|
0.001,308.00 (0٪) |
Capital : 1.8 Thousand billion |
|
Date : 2022-10-22 6 Months |
Forecast :
Achieved :
|
0.001,348.00 (0٪) |
Capital : 1.8 Thousand billion |
|
Date : 2022-07-21 3 Months |
Forecast :
Achieved :
|
0.00907.00 (0٪) |
Capital : 900 billion |
Fiscal year 2022-03-20
3,721
Real profit
3,530
Cash profit
Date | Profit | Capital | ||
---|---|---|---|---|
Date : 2022-05-15 assembly |
Real :
Spot :
|
3,721.003,530.00 (-95٪) |
Capital : 900 billion |
|
Date : 2022-05-02 12 Months |
Forecast :
Achieved :
|
0.003,721.00 (0٪) |
Capital : 900 billion |
|
Date : 2021-11-16 6 Months / Audited |
Forecast :
Achieved :
|
0.001,527.00 (0٪) |
Capital : 900 billion |
|
Date : 2021-10-21 6 Months |
Forecast :
Achieved :
|
0.001,528.00 (0٪) |
Capital : 900 billion |
|
Date : 2021-07-20 3 Months |
Forecast :
Achieved :
|
0.00743.00 (0٪) |
Capital : 900 billion |
Fiscal year 2021-03-19
3,754
Real profit
3,547
Cash profit
Date | Profit | Capital | ||
---|---|---|---|---|
Date : 2021-05-17 assembly |
Real :
Spot :
|
3,754.003,547.00 (-94٪) |
Capital : 600 billion |
|
Date : 2021-05-04 12 Months |
Forecast :
Achieved :
Adjustment :
|
0.003,754.00 (0٪)100.00 |
Capital : 600 billion |
|
Date : 2021-02-02 |
Forecast :
|
3,585.00 |
Capital : 600 billion |
|
Date : 2021-01-19 9 Months |
Forecast :
Achieved :
|
0.002,726.00 (0٪) |
Capital : 600 billion |
|
Date : 2020-10-21 6 Months |
Forecast :
Achieved :
|
0.001,913.00 (0٪) |
Capital : 600 billion |
|
Date : 2020-07-20 3 Months |
Forecast :
Achieved :
|
0.00746.00 (0٪) |
Capital : 600 billion |
Fiscal year 2023-03-20
1,835
Achieved
Date | Profit | Capital | ||
---|---|---|---|---|
Date : 2023-01-18 9 Months |
Forecast :
Achieved :
|
0.001,835.00 (0٪) |
Capital : 1.8 Thousand billion |
|
Date : 2022-11-20 6 Months / Audited |
Forecast :
Achieved :
|
0.001,308.00 (0٪) |
Capital : 1.8 Thousand billion |
|
Date : 2022-10-22 6 Months |
Forecast :
Achieved :
|
0.001,348.00 (0٪) |
Capital : 1.8 Thousand billion |
|
Date : 2022-07-21 3 Months |
Forecast :
Achieved :
|
0.00454.00 (0٪) |
Capital : 1.8 Thousand billion |
Fiscal year 2022-03-20
1,860
Real profit
1,765
Cash profit
Date | Profit | Capital | ||
---|---|---|---|---|
Date : 2022-05-15 assembly |
Real :
Spot :
|
1,860.001,765.00 (-95٪) |
Capital : 1.8 Thousand billion |
|
Date : 2022-05-02 12 Months |
Forecast :
Achieved :
|
0.001,860.00 (0٪) |
Capital : 1.8 Thousand billion |
|
Date : 2021-11-16 6 Months / Audited |
Forecast :
Achieved :
|
0.00764.00 (0٪) |
Capital : 1.8 Thousand billion |
|
Date : 2021-10-21 6 Months |
Forecast :
Achieved :
|
0.00764.00 (0٪) |
Capital : 1.8 Thousand billion |
|
Date : 2021-07-20 3 Months |
Forecast :
Achieved :
|
0.00372.00 (0٪) |
Capital : 1.8 Thousand billion |
Fiscal year 2021-03-19
1,251
Real profit
1,182
Cash profit
Date | Profit | Capital | ||
---|---|---|---|---|
Date : 2021-05-17 assembly |
Real :
Spot :
|
1,251.001,182.00 (-94٪) |
Capital : 1.8 Thousand billion |
|
Date : 2021-05-04 12 Months |
Forecast :
Achieved :
Adjustment :
|
0.001,251.00 (0٪)100.00 |
Capital : 1.8 Thousand billion |
|
Date : 2021-02-02 |
Forecast :
|
1,195.00 |
Capital : 1.8 Thousand billion |
|
Date : 2021-01-19 9 Months |
Forecast :
Achieved :
|
0.00909.00 (0٪) |
Capital : 1.8 Thousand billion |
|
Date : 2020-10-21 6 Months |
Forecast :
Achieved :
|
0.00638.00 (0٪) |
Capital : 1.8 Thousand billion |
|
Date : 2020-07-20 3 Months |
Forecast :
Achieved :
|
0.00249.00 (0٪) |
Capital : 1.8 Thousand billion |